In the 2012 Annual conference of Japan Society for Bioscience, Biotechnology, and Agrochemistry, Ms. Rie Kugimiya, our general manager in Business development will make a presentation "Fermentation drug discovery using a cycrosporin derivative take by disparity mutagenesis". Also our scientist Dr. Ken Kasahara will make a presentation "Disparity mutagensis; Novel mutation method with a genome wide mutation spectrum and it's analysis". We will also have a collaborative presentation with University of Tokyo, University of Kyoto, and Municipal University of Osaka at the same conference.For more detail click here.(only in Japanese)

In the 6th annual conference of Society of Genome microbiology Japan, Neo-Morgan Laboratory will make a presentation about the acommplishment we had made through collaboration with Tokyo University of Agriculture.For more detail click here.(only in Japanese)

A paper written by our founder, Dr. Mitsuru Furusawa was published in a Open Journal of Genetics. The title is "Implications of double-stranded DNA structure for development, cancer and evolution". For more detail click here.

Neo-Morgan Laboratory was covered in the Nikkei Industrial Paper, a Japanese newspaper, for the expansion of our research facility.

Neo-Morgan Laboratory was nominated as the FAST 50 technology company in Japan by the Deroitte Touche Tohmatsu, an international auditing firm. We have been nominated 3 years in a row. For more detail click here.(Only in Japanese)

Our CEO, Tomohiro Fujita has made his presentation in preliminary session in Bio Japan 2011 held in Yokohama. He has made his panel discussion with the title of "Preliminary session from the front line; Growth strategy of the biotech leaders". Thank you for all of your audience.

Neo-Morgan Laboratory was covered in a "Prime News" in BS Fuji, a Japanese television program. Our CEO, Tomohiro Fujita has made his comment on our strategy in algae as a biomass and it's challenge. For more detail click here. (Only in Japanese)

Our General director of Business development, Rie Kugimiya has made a presentation in16th Japan-German Workshop on Enzyme Technology held in Toyama, Japan. For more detail click here. Thank you for all of your audience.

Neo-Morgan Laboratory has supported "International Congress of Bacteriology and Applied Microbiology" held in Sapporo, Japan as a session sponsor. Also our Director of Global business development, Kengo Fukui has made his presentation with the title of "Fermentation drug discovery using a cycrosporin derivative take by disparity mutagenesis"

Our collaboration between Hirosima institute of technology has recieved a grant from the Bio-oriented Technology Research Advancement Institution inside National Agriculture and Food Research Organization; NARO as a research for promoting innovative basic science development. For more detail click here. (Only in Japanese)

Neo-Morgan Laboratory has announced the formation of Joint venture between IHI corporation and Gene and Genetechnology K.K. for the purpose of developing a fuel producing algae. For more detail click here (Only in Japanese)

Our CEO, Tomohiro Fujita has made his presentation in a seminar held by Japan Association of chemical innovation.

Our CEO, Tomohiro Fujita and the Director of algal business, Ken Nakahara has made their presentation in "Business strategy using an algal technology" held by Technical Information Institute K.K. For more detail click here .(Only in Japanese)

Our CEO, Tomohiro Fujita has made his lecture in Nara Institute of Science and technology.

Our CEO Tomohiro Fujita has made his presentation in 84th May Festival held in the university of Tokyo. For more detail click here. (Only in Japanese)

Our Director of Global Business Development, Kengo Fukui has presented a recent update in Symposium of Industrial biotechnology, fuel and chemicals held in Seatle, Washington, U.S. Our presentation was about co-fermentation yeast; Xyno project. Thank you for many of your audience.

Our Collaboration with Osaka University has been covered by several media such as a TIME magazine and BBC.The tweeting mouse is not our primary target. Our target is to contribute to the drug development by creating natural like pathological model mouse that could not be archive by a simple gene knock out technology.We have been disclosing these attracting news to continue the collaboration, which requires a large sum of resource.

Our collaboration with Dr. Hiroko Abe in Advanced Industrial Science and Technology(AIST) was covered by Nikkei Industrial Newspaper. The collaboration was to aim the development of yeast strain for Bio-Pharmacuetical expression.

Our collaboration with Dr. Uchimura in Osaka University was covered by Yomiuri News paper in December 21 and Agence France-Presse in December 22nd. "Tweeting mouse" or "Singing mouse" has been the result of our collaboration for development of application using Disparity Mutagenesis.

Chiba University had awarded the golden prize in the iGEM, a international championship in the world of bio-synthetic technology. Neo-Morgan Laboratory has been a sponsor for Chiba university team. Congratulation for your success!

Neo-Morgan Laboratory was awarded as a one of the rapid growing technology company in "Deloitte Japanese Technology FAST 50". Neo-Morgan will be 2nd in the Green technology sector.

Our collaboration with Osaka University was covered by Sankei Newspaper with the title of "Development of tweeting mouse done by Osaka University". This successful achievement was result from our platform technology with the collaboration with Prof. Yagi and Dr. Uchimura.

Our scientist, Dr. Shuntaro Yano has presented in the annual meeting of The Society of Chemical Engineers, Japan held in Miyazaki. We have presented some example of "The development of the industrial yeast strain using Disparity Mutagenesis Technology".

The book, "Disparity mutagenesis Theory" which was written by our founder, Dr. Mitsuru Furusawa has been published. This book was written for non-biological person and easy to understand the background of our technology. Please find them in the bookstore near you.

Our Technical Directer, Dr. Takayuki Horiuchi has presented in the 42nd annual meeting of "The Society of Chemical Engineers" held in Doshisha University with the title of "Development of high protein expression cell-line with the disparity mutagenesis technology".

Our CEO, Tomohiro Fujita has presented our perspective and technology as "Industrial Algal Application"at the seminar held by Mega-Seminar Service KK in August 27th. Thank you for many attendance.

Neo-Morgan Laboratory has presented the fasinating result held with Osaka University with the title of "Development of new phenotype with the high mutation rate and it's influence to mammalian population" in the Annual meeting of "Society of Evolutional Studies in Japan". The meeting was held during Aug. 2nd to 5th in Tokyo Institute of Technology.

Technology of Neo-Morgan Laboratory was introduced in the "COURRiER Japon; September issued" in the column "Hear the footsteps of the Future".

Neo-Morgan Laboratory was covered by "Nikkei Industrial", One of the largest newspaper in the industry. Our perspective and insight to algal industry was posted in the column "Next Generation Technology; Challenge to 2030".

We will be attending Pacific Rim Summit on Industrial Biotechnology and Bioenergy held from November 8th to 11th in Honolulu, Hawaii. We will be presenting Our Ethanol Production Yeast "Xyno" at the poster session on the 11th.Please come to our presentation if your near by.

Our Algal business will be introduced in NHK Program called "Ohayo Nippon" on September 9th.Our Algal business focusing not only bio-fuel but all also bio-material, pharmaceutical substance,and other is planned to be on air.

Nikkei Industrial newspaper has pressed our business, research and development of the yeast for ethanol production which used the wasted material biomass. Although the yeast, which introduced on newspaper, uses gene modification technology, we also have non-gene modified yeast which exceeds the transgenics bacillus. Please contact us for more precise question.

Takayuki, HORIUCHI, principal scientist, gave a presentation at the annual meeting of Japanese Association for Animal Cell Technology titled, " Creation of High-IgG Producing Host Cell Lines by Disparity Mutagenesis Technology"for more information

Seminar " Future possibility and issues of Algae application and development" sponsored by Technical information Center, was held in Tokyo. In those seminar, our CEO Tomohiro Fujita presented the advantage of "green business" and our research and business strategy in our algae business.

Masakatsu Mori, Accenture Inc. supreme advisor and the chairman of the Association of Corporate executive in Japan, was inaugurated as the director of our company.

In accordance with our recent business progress, we have decided to renew our corporate logo mark. We will gradually introduce it from April 6.Thank you for your understanding.

Rie Kugimiya, Business Development, Manager, gave a presentation on breeding approaches of our company in the symposium "Technology for designing environmentally friendly microbial factory" at the Annual Meeting of Japan Society for Bioscience, Biotechnology and Agrochemistry 2009, held in Fukuoka.Thank you very much for many of you who had attended our presentation.

Professor Minamisawa of Tohoku University and Neo-Morgan Laboratory Inc. jointly presented "Obtaining a mutant strain with high NO2 reductase activity in Bradyhizobium japonicum using a mutant dnaQ plasmid" at the Annual Meeting of Japan Society for Bioscience, Biotechnology and Agrochemistry 2009, held in Fukuoka.

Our approaches towards algae business were introduced in the article in Nikkei Ecology, April 2009 Issue.